The ASD families were genotyped on the Illumina Infinium® 1Mv1 (338 families), Infinium® 1Mv3 Duo (1,191 families) or the HumanOmni2.5-8 (996 families) microarrays (Illumina Inc, USA). All three microarray types had over 180 probes within the BP1-BP2 region. CNV prediction was performed by PennCNV (PN) [Wang et al. 2007 (link)], QuantiSNP (QT) [Colella et al. 2007 (link)], and Gnosis [Sanders et al. 2011 (link)], using CNVision [Sanders et al. 2011 (link)]. Detailed CNV detection protocol was described in [Sanders et al. 2011 (link)]. Sample identity within the family, including correct assignment of paternity and maternity, was confirmed using genetically-inferred identity by descent for all study participants including the de novo deletion of BP1-BP2 in a proband.